MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2020-21)
- Udyam number
- UDYAM-MH-26-0056264
Samproj Pharma Private Limited
Samproj Pharma Private Limited - pharma in Pune, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹4.8 Cr
▲ 17% YoY
Net profit · FY 2025
₹4.37 Lakh
Net margin 0.9%
EBITDA · FY 2025
₹7.4 Lakh
EBITDA margin 1.5%
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹20 Lakh
Secured borrowings
Company age
6 yrs
Est. 2020
Employees · EPFO
18
Provident fund records
About Samproj Pharma Private Limited
Data last updated:
Samproj Pharma Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 18 November 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U85100PN2020PTC196107. Its GSTIN is 27ABECS9159E1Z0 (Maharashtra).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Jaleelahmed Bakhtiyar Ahmed Dafdar and Amol Arunrao Chaudhari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat – 101 Avalon Society Sun City Road Sinhgad Road Anandnagar Pune City, Maharashtra, India – 411051.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.8 Cr, a growth of 17% compared to the previous year. For the same year it recorded a net profit of ₹4.37 Lakh (net margin 0.9%) and EBITDA of ₹7.4 Lakh (EBITDA margin 1.5%). Revenue has grown at a compounded annual rate (CAGR) of 42% over three years.
The company has about 18 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹20 Lakh on record.
Samproj Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-26-0056264).
Company details
CIN U85100PN2020PTC196107
Registration Number 196107
Incorporation Date 18 November 2020
ROC Pune
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-MH-26-0056264
Key People
Jaleelahmed Bakhtiyar Ahmed Dafdar Director Amol Arunrao Chaudhari Director Prafulla Surajmal Somani Director Recognitions & Rankings of Samproj Pharma
Contact details
Samproj Pharma Private Limited's registered office is in Pune, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressFlat – 101 Avalon Society Sun City Road Sinhgad Road Anandnagar Pune City, Maharashtra, India – 411051
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Samproj Pharma Private Limited, buy the company report.
Comprehensive company report
Samproj Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Samproj Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Samproj Pharma Private Limited, buy the company report.
Financials of Samproj Pharma Private Limited
FY 2025 filings availableSamproj Pharma Private Limited reported revenue of ₹4.8 Cr (up 17% YoY) for FY 2025.
Revenue · FY 2025
₹4.8 Cr ▲ 17%
Net profit · FY 2025
₹4.37 Lakh margin 0.9%
EBITDA · FY 2025
₹7.4 Lakh margin 1.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 17%
3 years · compounded
▲ 42%
EBITDA CAGR growth
1 year
▼ 62%
3 years · compounded
▼ 13%
Revenue has grown at a compounded annual rate (CAGR) of 42% over three years, including 17% growth in the latest year. EBITDA fell 62% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹7.4 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4.37 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.5% | ||||
| Net Profit Margin | 0.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Samproj Pharma Private Limited, buy the company report.
Board of directors of Samproj Pharma Private Limited
Samproj Pharma has 5 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jaleelahmed Bakhtiyar Ahmed Dafdar | Director | 02 Dec 2020 | 5 Years 10 Months | Current |
| Amol Arunrao Chaudhari | Director | 02 Dec 2020 | 5 Years 10 Months | Current |
| Prafulla Surajmal Somani | Director | 18 Nov 2020 | 5 Years 11 Months | Current |
| Santosh Ramashankar Mishra | Director | 18 Nov 2020 | 5 Years 11 Months | Current |
| Sameer Bajare | Director | 18 Nov 2020 | 5 Years 11 Months | Current |
Peer comparison
Samproj Pharma Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Perivinc Pharmaceuticals Private Limited | ₹4.83 Cr (FY 2025) | 23.0% | Tal Viramgam, Gujarat, India | |||
| Samproj Pharma Private Limitedthis company | ₹4.8 Cr (FY 2025) | ₹4.37 Lakh | 0.9% | 17.0% | 18 | Pune, Maharashtra, India |
| Viralii Life Sciences Private Limited | ₹4.79 Cr (FY 2024) | 70.0% | Ahmedabad, Gujarat, India | |||
| Leonidaz Pharmaceuticals Private Limited | ₹4.78 Cr (FY 2024) | -8.0% | Tirur, Kerala, India | |||
| Golden Streak Drugs and Pharmaceuticals Limited | ₹4.76 Cr (FY 2025) | 1.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Samproj Pharma Private Limited, buy the company report.
Auditor
Samproj Pharma Private Limited is audited by VDA & ASSOCIATES for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VDA & ASSOCIATES | FY 2024 | 119179W |
Shareholding
The shareholding of Samproj Pharma Private Limited is on record for 4 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Samproj Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹20 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 26 Mar 2024 | 100915128 | Others | ₹20 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Samproj Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Samproj Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Samproj Pharma Private Limited has a workforce of 18 employees on its EPFO records as of Feb 04, 2025, across 1 active EPFO establishment.
Employee count
18
Active EPFO establishments
1
Employee growth
12.5%
GST
Samproj Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27ABECS9159E1Z0 | Maharashtra | Active | 18 Dec 2020 |
To see the full GST registrations and return filing status of Samproj Pharma Private Limited, buy the company report.
Recent activity
Samproj Pharma Private Limited has 7 board changes on record since 2020: 5 appointments and 2 cessations. The latest: Amol Arunrao Chaudhari ceased to be Additional Director on 06 Dec 2021.
AGM
Samproj Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Samproj Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune.
Charges
A charge with Others amounted to Rs. 20.00 Lakh with Charge ID 100915128 was registered on 26 Mar 2024.
Ceased
Amol Arunrao Chaudhari ceased to be Additional Director.
Ceased
Jaleelahmed Bakhtiyar Ahmed Dafdar ceased to be Additional Director.
Appointed
Amol Arunrao Chaudhari was appointed as Director.
Appointed
Jaleelahmed Bakhtiyar Ahmed Dafdar was appointed as Director.
Appointed
Prafulla Surajmal Somani was appointed as Director.
Appointed
Sameer Bajare was appointed as Director.
Appointed
Santosh Ramashankar Mishra was appointed as Director.
Incorporation
18 Nov 2020
Samproj Pharma Private Limited was registered on 18 Nov 2020 with Roc Pune & aged 5 years 11 months as per MCA records.
Frequently asked questions
Samproj Pharma is an active private limited company based in Pune, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 18 November 2020 (6+ years old) and is registered under CIN U85100PN2020PTC196107.
Samproj Pharma has 5 current directors:
- Jaleelahmed Bakhtiyar Ahmed Dafdar - Director
- Amol Arunrao Chaudhari - Director
- Prafulla Surajmal Somani - Director
- Santosh Ramashankar Mishra - Director
- Sameer Bajare - Director
The latest financial statements of Samproj Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Samproj Pharma is 27ABECS9159E1Z0, registered in Maharashtra.
The CIN (Corporate Identification Number) of Samproj Pharma is U85100PN2020PTC196107. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Samproj Pharma was incorporated on 18 November 2020, making it 6+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Samproj Pharma by revenue are Perivinc Pharmaceuticals Private Limited, Viralii Life Sciences Private Limited, Leonidaz Pharmaceuticals Private Limited, Golden Streak Drugs and Pharmaceuticals Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Amol Arunrao Chaudhari ceased to be Additional Director on 06 Dec 2021. Jaleelahmed Bakhtiyar Ahmed Dafdar ceased to be Additional Director on 06 Dec 2021. Amol Arunrao Chaudhari was appointed as Director on 02 Dec 2020. Samproj Pharma has 7 board changes on record in total.
Yes, Samproj Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-26-0056264).
The registered office of Samproj Pharma is at Flat – 101 Avalon Society Sun City Road Sinhgad Road Anandnagar Pune City, Maharashtra, India – 411051.
Samproj Pharma operates in the pharma industry, in the drug formulation and development segment.